Admission Date: [**2186-4-24**]        Discharge Date: [**2186-5-1**]  Date of Birth:  [**2147-9-24**]        Sex:  F  Service:  PSU   HISTORY OF PRESENT ILLNESS:  This patient is a 38-year-old female three years status post right lumpectomy and axillary dissection and chemotherapy and radiation now diagnosed with ductal carcinoma in situ in the right breast on needle localization of a mammographically-located microcalcifications here at [**Hospital6 2018**].
Cesarean section.
Breasts: There was a scar from a right lumpectomy with volume loss consistent with surgery, and there were no dominant masses noted on palpation.
HOSPITAL COURSE:  The patient was admitted to the [**Hospital3 **] [**Hospital **] [**First Name (Titles) **] [**Last Name (Titles) **] for further treatment and evaluation.
In addition she would also undergo an immediate reconstruction with possible [**Last Name (un) 5884**] flap that would be performed by Dr. [**Last Name (STitle) **] and Dr. [**First Name (STitle) 3228**], a combination procedure between the breast surgery service and the plastic surgery service.
On the day of admission, the patient was brought to the operating room, [**2186-4-24**], and the operation was performed; a skin-sparing right total mastectomy and reconstruction using an SIEA flap.
The patient tolerated the procedure well and received 5.7 L of Crystalloid fluid, and her estimated blood loss was 250 ml.
After heparin was bolused at 5000 units, a signal was retrieved, and the arm had been abducted, and temperature was elevated.
The patient was intensive care unit at this time being monitored carefully, and heparin drip was started at 500 units/hour with checks of PTT to make sure that she not in a supratherapeutic range, and plan was to keep the body in room temperature, warm.
On postoperative day #1, the patient was able to be extubated, and the heparin drip was continued.
The patient was receiving IV cephazolin at this point for prophylactic coverage.
The arm was abducted, and supportive maneuvers were made, but the flap was still noted to be pale and cool at this time.
Heparin subcutaneously was started stat, and IV heparin was resumed, and Lovenox was started as well at this time while flap monitoring was continued.
The patient was continued on Keflex, continued on Lovenox, and continued on oral pain medicine.
The patient is to avoid driving or operating heavy machinery while taking narcotic pain medicine.
The patient is to resume her home medications as she had been previously taking.
DISCHARGE MEDICATIONS:  Acetaminophen 325-650 mg p.o.
q.4-6 hours as needed for pain, aspirin 162 mg delayed release p.o.
daily, levothyroxine 25 mcg p.o.
daily, Percocet 5/325 [**1-1**] tab p.o.
q.4-6 hours as needed for pain, ferrous sulfate 325 mg p.o.
daily, Colace 100 mg p.o.
b.i.d., Protonix delayed release 40 mg p.o.
daily, zolpidem tartrate 5 mg p.o.
hs, cephalexin 500 mg p.o.
